The Role of Inflammation in the Pathogenesis of Cardiogenic Shock Secondary to Acute Myocardial Infarction: A

Irina Kologrivova1, Maria Kercheva1,2, Oleg Panteleev1,2

  • 1Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences, 111A Kievskaya, Tomsk 634012, Russia.

Biomedicines
|September 28, 2024
PubMed

Insights

Cardiogenic shock (CS) following myocardial infarction (MI) has high mortality. This review explores the systemic inflammatory response in CS pathogenesis, aiming to identify targeted anti-inflammatory therapies for better patient outcomes.

Area of Science:

  • Cardiology
  • Immunology
  • Pathophysiology

Background:

  • Cardiogenic shock (CS) is a severe complication of myocardial infarction (MI), associated with high mortality rates.
  • Current pharmaco-invasive treatments for MI complicated by CS (MI CS) have limited efficacy, necessitating novel therapeutic strategies.
  • The systemic inflammatory response plays a critical role in the progression of MI CS and subsequent multiple organ dysfunction.

Purpose of the Study:

  • To review the role of the systemic inflammatory response in the pathogenesis of MI CS.
  • To summarize current knowledge on the initiation and progression of inflammation in MI CS.
  • To discuss potential anti-inflammatory therapeutic approaches and future research directions.

Main Methods:

  • Literature review and synthesis of existing research on inflammation in MI CS.
  • Analysis of the progression from MI onset to systemic inflammation and organ dysfunction.
  • Discussion of anti-inflammatory strategies and identification of research gaps.

Main Results:

  • The systemic inflammatory response is a key driver in MI CS pathogenesis.
  • Inflammation progresses from localized myocardial injury to a generalized response, contributing to organ dysfunction.
  • Understanding inflammatory pathways is crucial for developing targeted therapies.

Conclusions:

  • Targeting the inflammatory component of MI CS pathogenesis offers a promising avenue for improving patient outcomes.
  • Identification of specific inflammatory phenotypes and endotypes in MI CS is essential for personalized treatment strategies.
  • Further research into anti-inflammatory therapies is warranted to reduce the high mortality associated with MI CS.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
2
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
2
Myocarditis II: Clinical features and Diagnostic Tests01:27

Myocarditis II: Clinical features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
2
Acute Coronary Syndrome II: Pathophysiology and clinical manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and clinical manifestations

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
3
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
Inflammation01:38

Inflammation

Overview
53.2K